Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iradimed Cp 1025 Willa Springs Dr. Winter Springs FL 32708 USA

www.iradimed.com P: 407-677-8022

Description:

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.

Key Statistics

Overview:

Market Capitalization, $K 531,888
Enterprise Value, $K 482,128
Shares Outstanding, K 12,664
Annual Sales, $ 65,560 K
Annual Net Income, $ 17,190 K
Last Quarter Sales, $ 17,450 K
Last Quarter Net Income, $ 4,540 K
EBIT, $ 20,040 K
EBITDA, $ 20,810 K
60-Month Beta 0.86
% of Insider Shareholders 42.60%
% of Institutional Shareholders 92.34%
Float, K 7,269
% Float 57.40%
Short Volume Ratio 0.40

Growth:

1-Year Return 3.70%
3-Year Return 44.58%
5-Year Return 81.66%
5-Year Revenue Growth 115.37%
5-Year Earnings Growth 213.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.39 on 02/08/24
Latest Earnings Date 05/02/24 [BMO]
Earnings Per Share ttm 1.36
EPS Growth vs. Prev Qtr -10.00%
EPS Growth vs. Prev Year 24.14%
Annual Dividend Rate, $ 0.63
Annual Dividend Yield 1.50%
Most Recent Dividend 0.630 on 12/21/23
Next Ex-Dividends Date 12/21/23
Dividend Payable Date 01/12/24
Dividend Payout Ratio 123.02%

IRMD Ratios

Ratio
Price/Earnings ttm 29.86
Price/Earnings forward 29.42
Price/Earnings to Growth N/A
Return-on-Equity % 24.62%
Return-on-Assets % 20.43%
Profit Margin % 26.22%
Debt/Equity 0.00
Price/Sales 7.84
Price/Cash Flow 28.72
Price/Book 7.22
Book Value/Share 5.66
Interest Coverage -1.80

IRMD Dividends

Date Value
12/21/23 $0.6300
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar